Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
144,017
-
Share change
-
+144,017
-
Total reported value
-
$902,466
-
Price per share
-
$6.27
-
Number of holders
-
10
-
Value change
-
+$902,466
-
Number of buys
-
10
Institutional Holders of KAZIA THERAPEUTICS LTD - SPONSORED ADS (KZIA) as of Q2 2025
As of 30 Jun 2025,
KAZIA THERAPEUTICS LTD - SPONSORED ADS (KZIA) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
144,017 shares.
The largest 10 holders included
Dauntless Investment Group, LLC, BARCLAYS PLC, UBS Group AG, RHUMBLINE ADVISERS, GAMMA Investing LLC, Arax Advisory Partners, SBI Securities Co., Ltd., MAI Capital Management, OSAIC HOLDINGS, INC., and Allworth Financial LP.
This page lists
10
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.